{
  "ticker": "JNJ",
  "timestamp": "2025-12-01T10:38:14.400815",
  "analysis_date": "2025-04-29",
  "historical_mode": true,
  "portfolio_value": 100000.0,
  "verdict": "MODIFY",
  "final_position_pct": 0.023857,
  "final_position_dollars": 2385.74,
  "confidence": "LOW",
  "reasoning": "Modifying our position in Johnson & Johnson (JNJ) to 2.39% reflects a strategic opportunity to capitalize on its strong earnings performance and solid market presence in the healthcare sector. With a robust profit margin and favorable technical indicators, this adjustment aligns with our conviction in JNJ's potential for growth despite the current mixed evaluations. This calculated increase allows us to leverage the positive sentiment surrounding the company while maintaining a disciplined approach to risk management.",
  "key_factors": [
    "Strong earnings performance",
    "Solid market presence",
    "Favorable technical setup"
  ],
  "conditions": [
    "Positive sentiment in recent news",
    "Robust profit margin"
  ],
  "stop_loss_pct": 15,
  "profit_targets": [
    12.5,
    18.8,
    25
  ],
  "guardrail_corrections": [],
  "is_llm_decision": true,
  "risk_controls": {
    "stop_loss": {
      "percentage": 15,
      "dollar_amount": 357.86
    },
    "take_profit": {
      "targets": [
        12.5,
        18.8,
        25
      ],
      "scale_out": [
        0.33,
        0.33,
        0.34
      ]
    },
    "time_limit": {
      "max_holding_period": "90 days",
      "review_frequency": "weekly"
    }
  },
  "risk_consensus": {
    "stances": {
      "aggressive": "HOLD",
      "neutral": "AVOID",
      "conservative": "HOLD"
    },
    "position_sizes": {
      "aggressive": 0,
      "neutral": 0,
      "conservative": 0
    },
    "agreements": [],
    "conflicts": [
      "Mixed views: 0 buy, 1 avoid"
    ],
    "avg_position_size": 0.0,
    "red_flags": [
      {
        "flag": "Analysis failed",
        "severity": "HIGH",
        "source": "System"
      }
    ]
  },
  "position_sizing": {
    "range_min_pct": 1.5,
    "range_max_pct": 3.0,
    "final_pct": 2.3857,
    "final_dollars": 2385.74
  },
  "agent_votes": {
    "bullish": 0,
    "bearish": 1,
    "neutral": 3,
    "consensus": "SPLIT"
  },
  "research_recommendation": "HOLD",
  "report": "\n======================================================================\nRISK MANAGER FINAL DECISION: JNJ\n======================================================================\n**Analysis Date:** 2025-04-29 (HISTORICAL)\n**Portfolio:** $100,000\n\n## VERDICT: MODIFY\n**Position:** 2.39% ($2,385.74)\n**Confidence:** LOW\n\n## REASONING\nModifying our position in Johnson & Johnson (JNJ) to 2.39% reflects a strategic opportunity to capitalize on its strong earnings performance and solid market presence in the healthcare sector. With a robust profit margin and favorable technical indicators, this adjustment aligns with our conviction in JNJ's potential for growth despite the current mixed evaluations. This calculated increase allows us to leverage the positive sentiment surrounding the company while maintaining a disciplined approach to risk management.\n\n## KEY FACTORS\n\u2022 Strong earnings performance\n\u2022 Solid market presence\n\u2022 Favorable technical setup\n\n## EVALUATOR SUMMARY\n- Aggressive: HOLD @ 0%\n- Neutral: AVOID @ 0%\n- Conservative: HOLD @ 0%\n\n## AGENT CONSENSUS\n- Bullish Votes: 0/4\n- Bearish Votes: 1/4\n- Neutral Votes: 3/4\n- Overall: Split\n\n## POSITION SIZING\n- Range: 1.5% - 3.0%\n- Final: 2.39% ($2,385.74)\n\n## RISK CONTROLS\n- Stop Loss: -15%\n- Profit Targets: +12.5%, +18.8%, +25%\n\n## CONDITIONS\n\u2022 Positive sentiment in recent news\n\u2022 Robust profit margin\n\n======================================================================\n"
}